Stock Scorecard



Stock Summary for 23andMe Holding Co - Class A (ME) - $3.15 as of 11/20/2024 8:25:44 PM EST

Total Score

13 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ME

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ME

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ME

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ME

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ME (23 out of 90)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0

Latest News for for ME

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador's Precision Medicines for Immunology & Inflammation 11/20/2024 12:30:00 PM
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs - 23andMe Holding ( NASDAQ:ME ) 11/12/2024 6:29:00 PM
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future - 23andMe Holding ( NASDAQ:ME ) 11/11/2024 10:30:00 PM
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future 11/11/2024 10:30:00 PM
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results - 23andMe Holding ( NASDAQ:ME ) 11/7/2024 10:54:00 PM
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results 11/7/2024 10:54:00 PM
23andMe Regains Compliance With Nasdaq Listing Requirements 10/30/2024 9:00:00 PM
23andMe Appoints Three New Independent Directors to Board - Cardlytics ( NASDAQ:CDLX ) , Ansys ( NASDAQ:ANSS ) 10/29/2024 11:30:00 AM
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South - 23andMe Holding ( NASDAQ:ME ) 10/17/2024 8:05:00 PM
Israel accused of implementing 'starvation plan' in Gaza 10/17/2024 4:00:00 AM

Financial Details for ME

Company Overview

Ticker ME
Company Name 23andMe Holding Co - Class A
Country USA
Description 23andMe, Inc., a consumer genetics and research company, is dedicated to developing a genetic database to unlock knowledge that leads to rapid discovery of new drug development targets. The company is headquartered in Sunnyvale, California with an additional office in Mountain View, California.
Sector Name REAL ESTATE & CONSTRUCTION
Industry Name BLANK CHECKS
Most Recent Quarter 9/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 3.15
Price 4 Years Ago 0.00
Last Day Price Updated 11/20/2024 8:25:44 PM EST
Last Day Volume 410,368
Average Daily Volume 1,135,824
52-Week High 20.40
52-Week Low 2.75
Last Price to 52 Week Low 14.55%

Valuation Measures

Trailing PE N/A
Industry PE 117.20
Sector PE 66.35
5-Year Average PE -64.15
Free Cash Flow Ratio 0.44
Industry Free Cash Flow Ratio 225.17
Sector Free Cash Flow Ratio 124.65
Current Ratio Most Recent Quarter 1.24
Total Cash Per Share 7.23
Book Value Per Share Most Recent Quarter 7.69
Price to Book Ratio 0.76
Industry Price to Book Ratio 7.40
Sector Price to Book Ratio 11.98
Price to Sales Ratio Twelve Trailing Months 0.39
Industry Price to Sales Ratio Twelve Trailing Months 0.47
Sector Price to Sales Ratio Twelve Trailing Months 4.06
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 17,514,600
Market Capitalization 55,170,990
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -113.92%
Reported EPS 12 Trailing Months -122.52
Reported EPS Past Year -46.44
Reported EPS Prior Year -0.66
Net Income Twelve Trailing Months -615,313,000
Net Income Past Year -666,704,000
Net Income Prior Year -311,656,000
Quarterly Revenue Growth YOY -33.60%
5-Year Revenue Growth -10.12%
Operating Margin Twelve Trailing Months -1.78

Balance Sheet

Total Cash Most Recent Quarter 126,601,000
Total Cash Past Year 216,488,000
Total Cash Prior Year 242,418,000
Net Cash Position Most Recent Quarter 126,601,000
Net Cash Position Past Year 216,488,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 188,520,000
Total Stockholder Equity Prior Year 377,188,000
Total Stockholder Equity Most Recent Quarter 101,929,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -130,243,000
Free Cash Flow Per Share Twelve Trailing Months -7.44
Free Cash Flow Past Year -173,975,000
Free Cash Flow Prior Year -176,700,000

Options

Put/Call Ratio 1.35
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.38
MACD Signal -0.40
20-Day Bollinger Lower Band 3.38
20-Day Bollinger Middle Band 6.51
20-Day Bollinger Upper Band 9.64
Beta 1.26
RSI 28.23
50-Day SMA 10.11
150-Day SMA 38.28
200-Day SMA 80.43

System

Modified 11/19/2024 6:30:58 AM EST